Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02320981 · ClinicalTrials.gov registry record
Mucosal Impedance in Pediatric Population
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 127
- Enrollment target
NCT02320981 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 127 participants.
The verdict
NCT02320981 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.
Interventions
- DIAGNOSTIC_TEST Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02320981
The ClinicalTrials.gov registry entry for NCT02320981 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance is the first listed.
NCT02320981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02320981 about?
NCT02320981 is a clinical study titled "Mucosal Impedance in Pediatric Population". Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.
What is the current status of trial NCT02320981?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2014-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02320981?
The interventions under investigation include: Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02320981?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.